Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001999480-24-000042
Filing Date
2024-11-12
Accepted
2024-11-12 16:24:40
Documents
76
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alto-20240930.htm   iXBRL 10-Q 1748032
2 EX-31.1 exhibit311-302certceo3q2024.htm EX-31.1 12913
3 EX-31.2 exhibit312-302certcfo3q2024.htm EX-31.2 12954
4 EX-32.1 exhibit321-906certceo3q2024.htm EX-32.1 8246
5 EX-32.2 exhibit322-906certcfo3q2024.htm EX-32.2 8257
11 alto-20240930_g1.jpg GRAPHIC 822900
  Complete submission text file 0001999480-24-000042.txt   9360844

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alto-20240930.xsd EX-101.SCH 59774
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alto-20240930_cal.xml EX-101.CAL 65501
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alto-20240930_def.xml EX-101.DEF 301810
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alto-20240930_lab.xml EX-101.LAB 622772
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alto-20240930_pre.xml EX-101.PRE 445056
79 EXTRACTED XBRL INSTANCE DOCUMENT alto-20240930_htm.xml XML 758314
Mailing Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041
Business Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041 773-255-5012
Alto Neuroscience, Inc. (Filer) CIK: 0001999480 (see all company filings)

EIN.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41944 | Film No.: 241448679
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)